Nasal polyps and Taste - impaired

Summary:

Taste - impaired is found among people with Nasal polyps, especially for people who are female, 60+ old.

The study analyzes which people have Taste - impaired with Nasal polyps. It is created by eHealthMe based on reports of 39 people who have Nasal polyps from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Nasal polyps?

Nasal polyps (masses that develop in the lining of the nose) is found to be associated with 389 drugs and 376 conditions by eHealthMe. Check the latest studies of Nasal polyps.

What is Taste - impaired?

Taste - impaired is found to be associated with 1,824 drugs and 3,116 conditions by eHealthMe. Check the latest studies of Taste - impaired.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

39 people who have Nasal Polyps and Taste - Impaired are studied.

Would you have Taste - impaired when you have Nasal polyps?

Gender of people who have Nasal Polyps and experienced Taste - Impaired *:

  • female: 58.82 %
  • male: 41.18 %

Age of people who have Nasal Polyps and experienced Taste - Impaired *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 29.63 %
  • 40-49: 18.52 %
  • 50-59: 14.81 %
  • 60+: 37.04 %

Common co-existing conditions for these people *:

  1. Asthma: 16 people, 41.03%
  2. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 10.26%
  3. Hypersensitivity: 2 people, 5.13%
  4. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 2.56%
  5. Multiple Allergies (allergy to multiple agents): 1 person, 2.56%
  6. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 2.56%
  7. Cough: 1 person, 2.56%

Common drugs taken by these people *:

  1. Dupixent: 19 people, 48.72%
  2. Nasonex: 8 people, 20.51%
  3. Advair Hfa: 7 people, 17.95%
  4. Alvesco: 7 people, 17.95%
  5. Xolair: 7 people, 17.95%
  6. Spiriva: 7 people, 17.95%
  7. Ventolin: 7 people, 17.95%
  8. Xhance: 4 people, 10.26%
  9. Symbicort: 2 people, 5.13%
  10. Proair Hfa: 2 people, 5.13%

Common symptoms for these people *:

  1. Nasopharyngitis (inflammation of the nasopharynx): 11 people, 28.21%
  2. Ligament Sprain (ligament stretched): 11 people, 28.21%
  3. Upper-Airway Cough Syndrome: 10 people, 25.64%
  4. Headache (pain in head): 10 people, 25.64%
  5. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 9 people, 23.08%
  6. Cough: 8 people, 20.51%
  7. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 7 people, 17.95%
  8. Fall: 7 people, 17.95%
  9. Oedema Peripheral (superficial swelling): 7 people, 17.95%
  10. Oropharyngeal Pain: 7 people, 17.95%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Taste - impaired?

- Check whether Taste - impaired is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Taste - impaired:

All the conditions that are associated with Taste - impaired:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Taste - impaired and Nasal polyps, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: